Infliximab for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Retrospective Study
Mary Beth F. Son(Boston Children's Hospital), Jane W. Newburger(Oregon Health & Science University), Elena Corinaldesi(Istituto Ramazzini), Adriana H. Tremoulet(George Washington University Hospital), Kimberlee Gauvreau(Boston Children's Hospital), Jane C. Burns(Rady Children's Hospital-San Diego), Annette Baker(Boston Children's Hospital), Virginia E. Watson(University of California San Diego), Robert P. Sundel(Boston Children's Hospital), David R. Fulton(Tufts Medical Center)
Cited by 201
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
|Circulation|2004|1.9k
Prevention of bacterial endocarditis. Recommendations by the American Heart Association
|Journal of Cardiothoracic and Vascular Anesthesia|1997|1.3k